![](/img/cover-not-exists.png)
Subcutaneous treprostinil for the treatment of severe non-operable chronic thromboembolic pulmonary hypertension (CTREPH): a double-blind, phase 3, randomised controlled trial
Sadushi-Kolici, Roela, Jansa, Pavel, Kopec, Grzegorz, Torbicki, Adam, Skoro-Sajer, Nika, Campean, Ioana-Alexandra, Halank, Michael, Simkova, Iveta, Karlocai, Kristof, Steringer-Mascherbauer, Regina, SLanguage:
english
Journal:
The Lancet Respiratory Medicine
DOI:
10.1016/S2213-2600(18)30367-9
Date:
November, 2018
File:
PDF, 421 KB
english, 2018